glp-1 agonist joint pain Full article: agonists: a game changer in treatment and addiction GLP-1 Joint Pain Relief: Biomarkers

You WK, McDonald DM

Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial

NT and WM wrote the neurological and psychiatric disorders section, MS wrote the musculoskeletal disorders section with input from GL and GB wrote the cancer section

A 2024 systematic review and meta-analysis suggested NAC may be helpful as an add-on therapy for adults with moderate-to-severe OCD, but results have not been consistent across all psychiatric conditions or studies.33 Researchers are still working to determine which patients are most likely to respond and whether NAC's benefits are large enough to produce meaningful improvements in day-to-day functioning

Larger trials with higher doses and longer treatment durations will be required to determine the clinical utility of this dual-receptor approach